Saudi Heart Association Position Statement on Adult Vaccinations for Patients with Cardiovascular Diseases
Evidence from randomized trials, observational studies, and real-world data supports the role of vaccines in reducing the risk of major adverse cardiovascular events in individuals with CVD. The SHA recommends the implementation of age-appropriate vaccinations against influenza, COVID-19, respiratory syncytial virus (RSV), herpes zoster, pneumococcal disease and meningococcal disease as an integral component of cardiovascular care. Recommendations emphasize routine vaccine assessment, integration into cardiology practice, healthcare provider engagement, patient education, and leveraging high-risk periods such as Hajj and Umrah for vaccination outreach.
Authors
- Waleed AlHabeeb (ORCID: https://orcid.org/0000-0003-2985-482X)
- Raed Aldahash (ORCID: https://orcid.org/0000-0001-9612-4072)
- Fayssal Farahat (ORCID: https://orcid.org/0000-0001-5186-2872)
- Mohammed Balghith (ORCID: https://orcid.org/0000-0002-4449-3308)
- Majid Alshamrani
- Mohamed Al-Moamary (ORCID: https://orcid.org/0000-0002-6919-7978)
- Yassmin Hanfi
Institutions
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Saud University (SA)
- King Abdulaziz Medical City (SA)
- King Abdullah International Medical Research Center (SA)
- Saudi Heart Association (SA)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Journal of the Saudi Heart Association
- Published
- 2025-12-01
- DOI
- https://doi.org/10.37616/2212-5043.1461
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- Moderna